HLA and it Relation With the Development of Proliferative Diabetic Retinopathy in Mexican Population

Sponsor

Asociación para Evitar la Ceguera en México (Other)

Overall Status

Completed

CT.gov ID

NCT00600236

Collaborator

Instituto Nacional de Referencia Epidemiológica (INdRE) (Other)

300

Enrollment

Location

Duration (Months)

7.5

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

One of the first causes of irreversible blindness in mexican population is diabetic retinopathy which is clearly diferent between patients the time of evolution and development of retinopathy and complications. The aim of this study is to explore the inmunogenetic profile and the influence of HLA in this variations of the sickness to predict the severity of diabetic complications.

Condition or Disease	Intervention/Treatment	Phase
Diabetes Mellitus Type 2 Proliferative Diabetic Retinopathy	Procedure: blood sample	Phase 3

Study Design

Study Type:

Interventional

Anticipated Enrollment :

300 participants

Allocation:

Non-Randomized

Intervention Model:

Parallel Assignment

Masking:

Single

Primary Purpose:

Prevention

Official Title:

HLA and it Relation With the Development of Proliferative Diabetic Retinopathy in Mexican Population

Study Start Date :

Sep 1, 2004

Actual Primary Completion Date :

Jan 1, 2008

Actual Study Completion Date :

Jan 1, 2008

Outcome Measures

Primary Outcome Measures

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years and Older

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

Diabetes mellitus type 2 with 10 years of diagnosis and no diabetic retinopathy
Diabetes mellitus type 2 with 10 years of diagnosis and proliferative retinopathy